| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
29,317 |
26,699 |
$4.28M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
39,342 |
36,519 |
$3.12M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,310 |
3,917 |
$657K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,170 |
1,076 |
$503K |
| 71045 |
Radiologic examination, chest; single view |
7,553 |
6,843 |
$403K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
10,522 |
9,655 |
$320K |
| 71046 |
Radiologic examination, chest; 2 views |
3,851 |
3,525 |
$304K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
31,703 |
12,793 |
$289K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,983 |
3,723 |
$228K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
9,416 |
8,130 |
$206K |
| 80053 |
Comprehensive metabolic panel |
28,326 |
24,597 |
$198K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
38,843 |
32,594 |
$194K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,641 |
2,482 |
$144K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,985 |
3,650 |
$134K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,980 |
3,647 |
$134K |
| G0378 |
Hospital observation service, per hour |
953 |
667 |
$129K |
| 86003 |
|
1,441 |
627 |
$95K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
2,699 |
765 |
$83K |
| 81025 |
|
11,420 |
10,406 |
$76K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,275 |
874 |
$73K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,575 |
1,485 |
$69K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,578 |
4,168 |
$62K |
| 70450 |
Computed tomography, head or brain; without contrast material |
642 |
569 |
$56K |
| 80050 |
General health panel |
1,407 |
1,308 |
$56K |
| 36415 |
Collection of venous blood by venipuncture |
29,186 |
23,138 |
$55K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
921 |
832 |
$53K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
7,621 |
7,021 |
$52K |
| 81003 |
|
29,039 |
26,185 |
$50K |
| 80074 |
|
1,245 |
1,136 |
$46K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,679 |
427 |
$38K |
| 84484 |
|
4,325 |
3,448 |
$34K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,393 |
465 |
$33K |
| 87070 |
|
3,399 |
2,879 |
$25K |
| 83690 |
|
5,310 |
4,789 |
$25K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
912 |
595 |
$22K |
| 87081 |
|
3,758 |
3,410 |
$21K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
416 |
216 |
$17K |
| 83880 |
|
647 |
593 |
$16K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,875 |
2,610 |
$15K |
| 83655 |
|
1,192 |
1,127 |
$14K |
| 83735 |
|
3,333 |
2,741 |
$14K |
| 87077 |
|
1,727 |
1,274 |
$14K |
| 86738 |
|
1,365 |
851 |
$13K |
| 84439 |
|
1,464 |
1,348 |
$13K |
| 87420 |
|
1,066 |
875 |
$11K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
469 |
427 |
$11K |
| 82785 |
|
672 |
622 |
$11K |
| 45384 |
|
28 |
27 |
$11K |
| 86703 |
|
994 |
927 |
$11K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,714 |
1,540 |
$9K |
| 87186 |
|
1,040 |
756 |
$9K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,131 |
1,050 |
$7K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
306 |
288 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
907 |
830 |
$7K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,424 |
1,296 |
$6K |
| 83540 |
|
1,109 |
1,040 |
$6K |
| 86780 |
|
501 |
455 |
$6K |
| 97161 |
|
107 |
94 |
$6K |
| 59025 |
Fetal non-stress test |
89 |
54 |
$5K |
| 81001 |
|
1,897 |
1,743 |
$5K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
104 |
98 |
$5K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
13 |
13 |
$4K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,831 |
1,548 |
$4K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
140 |
107 |
$4K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
569 |
470 |
$3K |
| 86592 |
|
723 |
700 |
$3K |
| 80076 |
|
686 |
592 |
$3K |
| 83605 |
|
395 |
326 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
221 |
163 |
$3K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
44 |
42 |
$3K |
| 74018 |
|
54 |
52 |
$3K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
12 |
12 |
$3K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
14 |
12 |
$2K |
| 97602 |
|
167 |
105 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
578 |
508 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
31 |
29 |
$2K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
19 |
13 |
$2K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
51 |
42 |
$2K |
| 82550 |
|
487 |
430 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
41 |
36 |
$2K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
14 |
13 |
$2K |
| 85730 |
|
464 |
421 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
348 |
291 |
$1K |
| 80069 |
|
297 |
135 |
$1K |
| 85610 |
|
517 |
474 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
220 |
166 |
$1K |
| 82553 |
|
148 |
129 |
$928.38 |
| 97010 |
|
1,784 |
468 |
$836.59 |
| 72100 |
|
14 |
14 |
$716.20 |
| 80047 |
|
107 |
97 |
$659.38 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
29 |
28 |
$536.60 |
| 87205 |
|
102 |
91 |
$463.09 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
40 |
37 |
$432.85 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,103 |
2,141 |
$377.94 |
| 81002 |
|
184 |
154 |
$342.66 |
| 94760 |
|
49 |
28 |
$322.22 |
| A6209 |
Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
187 |
86 |
$315.59 |
| 36591 |
|
215 |
101 |
$260.92 |
| 86328 |
|
23 |
12 |
$232.22 |
| 82728 |
|
55 |
51 |
$204.87 |
| 87147 |
|
46 |
37 |
$202.45 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
60 |
47 |
$196.33 |
| 87040 |
|
20 |
12 |
$151.13 |
| 96376 |
|
166 |
52 |
$128.27 |
| 83550 |
|
54 |
50 |
$122.63 |
| 97014 |
|
625 |
169 |
$118.47 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
125 |
64 |
$102.25 |
| 82465 |
|
27 |
25 |
$95.72 |
| 85379 |
|
17 |
13 |
$92.23 |
| 84478 |
|
14 |
13 |
$83.07 |
| 86308 |
|
14 |
14 |
$81.61 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,246 |
785 |
$70.38 |
| 11721 |
|
12 |
12 |
$42.97 |
| 81005 |
|
16 |
13 |
$37.91 |
| A6207 |
Contact layer, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing |
74 |
42 |
$28.64 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
60 |
52 |
$19.08 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
87 |
66 |
$12.66 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
25 |
16 |
$12.66 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
35 |
27 |
$5.10 |
| A6446 |
Conforming bandage, non-elastic, knitted/woven, sterile, width greater than or equal to three inches and less than five inches, per yard |
28 |
12 |
$1.33 |
| A9270 |
Non-covered item or service |
252 |
182 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
31 |
28 |
$0.00 |
| J3490 |
Unclassified drugs |
17 |
14 |
$0.00 |
| 86318 |
|
35 |
30 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
13 |
12 |
$0.00 |